Concourse Financial Group Securities, Inc. Gossamer Bio, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.67 Billion
Q4 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share
Q4 2024 Feb 13, 2025	BUY	$0.66 - $1.07 $0 - $0
Q3 2024 Oct 10, 2024	BUY	$0.79 - $1.25 $0 - $0
Q2 2024 Jul 23, 2024	BUY	$0.51 - $1.27 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$0.8 - $1.51 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$0.48 - $1.08 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$0.78 - $1.82 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$0.78 - $1.82 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$0.98 - $1.53 $0 - $0
Q1 2023 May 15, 2023	BUY	$0.96 - $2.92 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$1.74 - $12.87 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$7.21 - $14.88 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$5.97 - $9.97 $0 - $0
Q1 2022 May 09, 2022	BUY	$8.44 - $12.49 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$10.12 - $14.07 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$7.25 - $13.23 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$8.0 - $9.75 $0 - $0
Q1 2021 May 13, 2021	BUY	$8.63 - $10.94 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$8.3 - $13.59 $0 - $0
Q3 2020 Nov 13, 2020	BUY	$11.3 - $14.75 $0 - $0
Q2 2020 Aug 13, 2020	BUY	$9.52 - $15.98 $0 - $0
Q1 2020 May 13, 2020	BUY	$8.0 - $15.48 $0 - $0
Q4 2019 Feb 14, 2020	BUY	$14.82 - $26.79 $0 - $0
Q3 2019 Nov 13, 2019	BUY	$16.02 - $22.47 $0 - $0
Q2 2019 Aug 13, 2019	BUY	$16.12 - $22.89 $0 - $0
Q1 2019 May 15, 2019	BUY	$17.58 - $23.97 $0 - $0

Others Institutions Holding GOSS

# of Institutions

116

Shares Held

163M

Call Options Held

821K

Put Options Held

557K

Octagon Capital Advisors LP New York, NY

18.4M
Shares

$21.7 Million
3.68% of portfolio
Nea Management Company, LLC Timonium, MD

18.1M
Shares

$21.3 Million
1.16% of portfolio
Vanguard Group Inc Valley Forge, PA

10M
Shares

$11.8 Million
0.0% of portfolio
Alyeska Investment Group, L.P. Chicago, IL

8.81M
Shares

$10.4 Million
0.03% of portfolio
Arch Venture Management, LLC Chicago, IL

8.06M
Shares

$9.51 Million
4.56% of portfolio

View Full List

About Gossamer Bio, Inc.

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $111M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

More about GOSS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account